glp 1 agonist uses GLP-1 Receptor Shortage: Challenges and Solutions in Type 2 Diabetes Care GLP-1 Receptor Agonists | New
Description
Glucagon-like peptide-1 (GLP-1), as one of the important targets for the treatment of type 2 diabetes mellitus (T2DM), has obvious therapeutic effect, short half-life and easy to be cleared
GLP-1 receptor agonists, offering clinically proven and durable weight-loss outcomes, are thus positioned to capture expanding demand in obesity management, driving market growth globally and complementing their use in diabetes care
Initial lab test: Included Your provider may order blood work to confirm eligibility
Mahalingam S, Bellamkonda R, Arumugam MK, Perumal SK, Yoon J, Casey C, et al
Youve likely heard buzz (and seen commercials) about GLP-1 drugs for weight management, like semaglutide (Wegovy) or tirzepatide (Zepbound)
